XWELL Inc (XWEL)
1.80
+0.38
(+26.76%)
USD |
NASDAQ |
Apr 24, 16:00
1.60
-0.20
(-11.11%)
Pre-Market: 08:24
XWELL Free Cash Flow: -18.45M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.45M |
| September 30, 2023 | -22.52M |
| June 30, 2023 | -28.39M |
| March 31, 2023 | -34.60M |
| December 31, 2022 | -31.02M |
| September 30, 2022 | -17.67M |
| June 30, 2022 | -1.521M |
| March 31, 2022 | 7.755M |
| December 31, 2021 | 6.971M |
| September 30, 2021 | -7.795M |
| June 30, 2021 | -20.76M |
| March 31, 2021 | -29.74M |
| December 31, 2020 | -29.36M |
| September 30, 2020 | -20.37M |
| June 30, 2020 | -14.89M |
| March 31, 2020 | -6.098M |
| December 31, 2019 | -2.388M |
| September 30, 2019 | -4.652M |
| June 30, 2019 | -4.505M |
| March 31, 2019 | -6.495M |
| December 31, 2018 | -9.682M |
| September 30, 2018 | -11.08M |
| June 30, 2018 | -13.49M |
| March 31, 2018 | -14.76M |
| December 31, 2017 | -16.88M |
| Date | Value |
|---|---|
| September 30, 2017 | -18.56M |
| June 30, 2017 | -18.19M |
| March 31, 2017 | -8.699M |
| December 31, 2016 | -8.507M |
| September 30, 2016 | 7.77M |
| June 30, 2016 | 5.689M |
| March 31, 2016 | -4.584M |
| December 31, 2015 | -2.571M |
| September 30, 2015 | -21.72M |
| June 30, 2015 | -23.24M |
| March 31, 2015 | -23.56M |
| December 31, 2014 | -28.63M |
| September 30, 2014 | -27.96M |
| June 30, 2014 | -27.01M |
| March 31, 2014 | -28.57M |
| December 31, 2013 | -24.91M |
| September 30, 2013 | -25.97M |
| June 30, 2013 | -45.58M |
| March 31, 2013 | -40.89M |
| December 31, 2012 | -37.22M |
| September 30, 2012 | -29.94M |
| June 30, 2012 | -5.104M |
| March 31, 2012 | -5.116M |
| December 31, 2011 | -5.407M |
| September 30, 2011 | -5.771M |
Free Cash Flow Range, Past 5 Years
-34.60M
Minimum
Mar 2023
7.755M
Maximum
Mar 2022
-14.74M
Average
-17.67M
Median
Sep 2022
Free Cash Flow Benchmarks
| Fonar Corp | 12.18M |
| ProPhase Labs Inc | -14.50M |
| Applied DNA Sciences Inc | -7.592M |
| Veracyte Inc | 34.26M |
| OncoCyte Corp | -23.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.201M |
| Cash from Investing (Quarterly) | 6.822M |
| Free Cash Flow Per Share (Quarterly) | -0.8276 |
| Free Cash Flow to Equity (Quarterly) | -3.467M |
| Free Cash Flow to Firm (Quarterly) | -3.467M |
| Free Cash Flow Yield | -245.5% |